Microba Life Sciences LimitedASX: MAP

Q1 FY27 Quarterly Activities Report & Appendix 4C

· Issued by Microba Life Sciences Limited via ASX

Filed with ASX ·

On 6ix: 6ix.com/news/q1-fy27-quarterly-activities-report-and-appendix-4c-1

Watch Microba Life Sciences' latest callMicroba Life Sciences (ASX:MAP) Q4 2025 Earnings Call · Replay · Jul 22, 2025Read the transcript of Microba Life Sciences (ASX:MAP) Q4 2025 Earnings Call

ASX Announcement 20 October 2026 Q1 FY27 Quarterly Activities Report & Appendix 4C Record core testing revenue, up 31% vs PCP; GI Navigator launched in Australia and the United Kingdom; cost base reset underway. Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”), a...

View Attachment

6ix is reading this filing.

Microba Life Sciences Limited on 6ix

Story so far

Earlier from Microba Life Sciences

Later from Microba Life Sciences

All Microba Life Sciences news releases